Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

PYY(3-36) and exendin-4 reduce food intake and activate neuronal circuits in a synergistic manner in mice

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Nonsulfated cholecystokinins in cerebral neurons

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. PKA, novel PKC isoforms, and ERK is mediating PACAP auto-regulation via PAC1R in human neuroblastoma NB-1 cells

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. VIP/PACAP receptors in cerebral arteries of rat: characterization, localization and relation to intracellular calcium

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Gastric cancer and gastrin: on the interaction of Helicobacter pylori gastritis and acid inhibitory induced hypergastrinemia

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Investigating the effect of sex and ketosis on weight-loss-induced changes in appetite

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Fructose malabsorption induces cholecystokinin expression in the ileum and cecum by changing microbiota composition and metabolism

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Opinion: Stop Gaming Peer Review

    Research output: Contribution to journalComment/debateCommunication

  • Marina Kjaergaard
  • Casper Bo Gravesen Salinas
  • Jens F Rehfeld
  • Anna Secher
  • Kirsten Raun
  • Birgitte S Wulff
View graph of relations

Peptide YY(3-36) ((PYY(3-36)) and glucagon like peptide 1 (GLP-1) in combination reduce food intake and body weight in an additive or synergistic manner in animal models and in humans. Nevertheless, the mechanisms behind are not completely understood. The present study aims to investigate the effect of combining PYY(3-36) and the GLP-1 receptor agonist exendin-4 (Ex4) by examining acute food intake and global neuronal activation as measured by c-fos in C57BL/6 J mice. An additive reduction in food intake was found 1.5 h after s.c dosing with the combination of PYY(3-36) (200 μg/kg) and Ex4 (2.5 μg/kg). This was associated with a synergistic enhancement of c-fos reactivity in central amygdalar nucleus (CeA), rostral part of the mediobasal arcuate nucleus (ARH), supratrigeminal nucleus (SUT), lateral parabrachial nucleus (PB), area postrema (AP) and nucleus tractus solitarius (NTS) compared to vehicle, PYY(3-36) and Ex4 individually dosed mice. The regions activated by Ex4 individually and PYY(3-36) and Ex4 in combination resembled each other, but the combination group had a significantly stronger c-fos response. Twenty-five brain areas were activated by PYY(3-36) and Ex4 in combination compared to vehicle versus nine brain areas by Ex4 individually. No significant increase in c-fos reactivity was found by PYY(3-36) compared to vehicle dosed mice. The neuronal activation of ARH and the AP/NTS to PB to CeA pathway is important for appetite regulation while SUT has not previously been reported in the regulation of energy balance. As PYY(3-36) and Ex4 act on different neurons leading to recruitment of different signalling pathways within and to the brain, an interaction of these pathways may contribute to their additive/synergistic action. Thus, PYY(3-36) boosts the effect of Ex4 possibly by inducing less inhibition of neuronal activity leading to an enhanced neuronal activity induced by Ex4.

Original languageEnglish
JournalNeuropeptides
Volume73
Pages (from-to)89-95
Number of pages7
ISSN0143-4179
DOIs
Publication statusPublished - Feb 2019

    Research areas

  • Amygdala/drug effects, Animals, Body Weight/drug effects, Eating/drug effects, Exenatide/pharmacology, Hypothalamus/drug effects, Mice, Neurons/drug effects, Peptide Fragments/pharmacology, Peptide YY/pharmacology, Proto-Oncogene Proteins c-fos/metabolism

ID: 56926907